Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Reference:EU Regulation (EU) No 520/2012 - performance of pharmacovigilance activities 20-Jun-12 Annex III 1.: Difference between revisions

From GxPlex

Jump to: navigation, search
m 1 revision imported
imported>GxPlexBot
Import from GxPlex Excel
Line 5: Line 5:
1.
1.
|RefLanguage=EN
|RefLanguage=EN
|RefTagsEN=
|RefTags=TAG-00285-Pha-enk ++ TAG-00033-Pro-oto ++ TAG-00340-Req-nfo ++ TAG-00274-Fin-Spo
|RefTagsOriginal=
|RefModule=2
|RefTagsFR=
|RefUnit=2.1.3
}}
}}


Line 15: Line 15:
|-
|-
! colspan="2" class="gplx-infobox-header" | Reference Details
! colspan="2" class="gplx-infobox-header" | Reference Details
|-
! Module
| Module 2 — Unit 2.1.3
|-
|-
! Scope
! Scope
Line 32: Line 35:
|  
|  
|-
|-
! Tags (EN)
! Tags
|  
| [[Glossary:TAG-00285-Pha-enk|Post-authorisation safety study]], [[Glossary:TAG-00033-Pro-oto|Protocol]], [[Glossary:TAG-00340-Req-nfo|Requirements]], [[Glossary:TAG-00274-Fin-Spo|Sponsor final report]]
|-
! Tags (original language)
|  
|-
! Tags (FR)
|  
|-
|-
! Comment
! Comment

Revision as of 17:29, 15 July 2026



Document information
Reference EU Regulation (EU) No 520/2012 - performance of pharmacovigilance activities 20-Jun-12
Validity area EU
Scope(s) G
Document name Regulation (EU) No 520/2012 - performance of pharmacovigilance activities
Version / Revision 20-Jun-12
Status Current
Document type Regulatory requirement
Language(s) EN
Description Commission Implementing Regulation (EU) No 520/2012 of 19 June 2012 on the performance of pharmacovigilance activities provided for in Regulation (EC) No 726/2004 of the European Parliament and of the Council and Directive 2001/83/EC of the European Parliament and of the Council Text with EEA relevance

(Including NIS)

Official source Official link
Restricted access No
Submitted by Florian Adragna
Contributors


Reference Details
Module Module 2 — Unit 2.1.3
Scope G
Document part Annex III

1.

Language EN
Original entry by Florian Adragna
Contributors
Tags Post-authorisation safety study, Protocol, Requirements, Sponsor final report
Comment PASS protocol, abstract and final study report requirements

Content

ANNEX III

Protocols, abstracts and final study reports for post-authorisation safety studies

1. Format of the study protocol [...]